Pharmaxis Of Australia Gets First CF Drug Clearance At Home
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaxis said it has received local clearance from regulators to market its Bronchitol (mannitol) for treating cystic fibrosis